Archive for October, 2009

h1

UK News: Government Green Paper Threat to DLA and AA for Over-65s (and a £20,000 Tax Bill)

2009 October 30

Reported by Benefits and Work, the UK government green paper on the proposed National Care Service includes a “ruinous” shocker for people turning 65 who claim Disability Living Allowance (DLA) or Attendance Allowance (AA). The proposals include:

  • Removal of entitlement to the middle rate of the care component of DLA, and,
  • A one-off tax payment of up to £20,000 either,
    • Payable on turning 65, or,
    • Recoverable from the elderly’s estate upon death.

The proposal suggests removing some or all of AA (the Benefits and Work page is unclear on this).

Benefits and Work say that the green paper suggests that the cost of care of one elderly person paid for by this tax would be between £17,000 and £20,000. The payment is means tested, so the poorest pensioner without many means or a house may be exempted.

As I read the website, however, this is only one of a range of suggestions. I suggest anyone claiming DLA and/or AA read the site for themselves. You can read more about the options and leave a comment here: http://careandsupport.direct.gov.uk/greenpaper/execsum/comment-page-52/#comment-6204

Members of Benefits and Work can read their article here: £20,000 shock birthday tax for all

Benefits and Work are a subscription organisation that offers advice and campaigns on behalf of those claiming a range of state benefits in the UK. A subscription costs just  £18.55 for a full year: http://www.benefitsandwork.co.uk/home

 

h1

A Brief Break

2009 October 23

Please note that I am taking a two day break. This means I will not be posting the Migraine Daily News or moderating comments over the weekend.

Take care.

h1

New Feature! Daily News Round-up

2009 October 21

From today, whenever I am well enough myself and able to access my computer, I will do a morning news round-up from around the web of articles relating to migraine. So, here’s today’s round-up:

h1

News: Warnings about side effects of NSAIDs

2009 October 15

The Guardian’s website carries an article looking at the risks of “high doses of some NSAIDs for a long time”. “NSAIDs” are “non-steroidal anti-inflamatory drugs” – that treat pain and inflammation. The best known NSAID is probably ibuprofen.

The article says that people taking NSAIDs in this way (which may include fellow migraine sufferers) have a slightly increased risk of heart attack, stroke and even, in very long-term use, arthritis. Older NSAIDs, such as ibuprofen, are also associated with stomach problems with long-term use (I myself have bouts of gastritis).

I should stress that the article says that lower dose, short term use does not carry any increased risk of heart attack, stroke or arthritis.

You can read the full Guardian article here:

h1

Open Journal Article: Two-stage case-control association study of dopamine-related genes and migraine

2009 October 12

Abstract:

Background

We previously reported risk haplotypes for two genes related with serotonin and dopamine metabolism: MAOA in migraine without aura and DDC in migraine with aura. Herein we investigate the contribution to migraine susceptibility of eight additional genes involved in dopamine neurotransmission.
Methods

We performed a two-stage case-control association study of 50 tag single nucleotide polymorphisms (SNPs), selected according to genetic coverage parameters. The first analysis consisted of 263 patients and 274 controls and the replication study was composed by 259 cases and 287 controls. All cases were diagnosed according to ICHD-II criteria, were Spanish Caucasian, and were sex-matched with control subjects.
Results

Single-marker analysis of the first population identified nominal associations of five genes with migraine. After applying a false discovery rate correction of 10%, the differences remained significant only for DRD2 (rs2283265) and TH (rs2070762). Multiple-marker analysis identified a five-marker T-C-G-C-G (rs12363125-rs2283265-rs2242592-rs1554929-rs2234689) risk haplotype in DRD2 and a two-marker A-C (rs6356-rs2070762) risk haplotype in TH that remained significant after correction by permutations. These results, however, were not replicated in the second independent cohort.
Conclusion

The present study does not support the involvement of the DRD1, DRD2, DRD3, DRD5, DBH, COMT, SLC6A3 and TH genes in the genetic predisposition to migraine in the Spanish population.

You can read the full article here: http://www.biomedcentral.com/1471-2350/10/95